ArticleOrphanet journal of rare diseases2018
Improving the analysis of composite endpoints in rare disease trials.
Martina McMenamin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it